½ÃÀ庸°í¼­
»óǰÄÚµå
1459522

¼¼°èÀÇ Ç÷°ü»öÀü ±â±â ½ÃÀå(2024-2028³â)

Global Vascular Embolization Devices Market 2024-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechNavio | ÆäÀÌÁö Á¤º¸: ¿µ¹® 167 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ç÷°ü»öÀü ±â±â ½ÃÀåÀº 2023-20281³â¿¡ 7¾ï 3,535¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 6.69%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ç÷°ü»öÀü ±â±â ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº Ç÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, Ç÷°ü»öÀü ±â±â¿¡ °ü·ÃµÈ ½ÅÁ¦Ç°ÀÇ ¹ß¸Å ¼ö Áõ°¡, °ü·Ã Ç÷°ü Áúȯ Á¦Ç°ÀÇ M&A Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024
Á¾·á³â 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2024³â 5.94%
CAGR 6.69%
ÁõºÐ¾× 7¾ï 3,535¸¸ ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¼ö³â°£ Ç÷°ü»öÀü ±â±â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿äÀÎÀÇ Çϳª·Î ÀÚµ¿Â÷ »ç°íÀÇ Áõ°¡¸¦ µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¥Ã³Ä³ÇÇÅÐ ¹× Á¤ºÎ Á¶Á÷À¸·ÎºÎÅÍÀÇ ½Å±Ô »öÀü ±â±â ±â¾÷¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø, »öÀüÁ¦Ç°¡¤½Ã¼úÀÇ Çõ½ÅÀÌ ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå ±¸µµ

  • ½ÃÀå ¿¡ÄڽýºÅÛ

Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð 2023
  • ½ÃÀå Àü¸Á 2023-2028

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

  • ¼¼°èÀÇ Ç÷°ü»öÀü ±â±â ½ÃÀå 2018-2022
  • ÃÖÁ¾»ç¿ëÀÚ ºÎ¹® ºÐ¼® 2018-2022
  • Á¦Ç° ºÎ¹® ºÐ¼® 2018-2022
  • Áö¿ªº° ºÎ¹® ºÐ¼® 2018-2022
  • ±¹°¡º° ºÎ¹® ºÐ¼® 2018-2022

Á¦5Àå Five forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀïÀÇ À§Çù
  • ½ÃÀå ÇöȲ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • Àü¹® Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ASCs : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : Á¦Ç°º°
  • ÄÚÀÏ ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ºñÄÚÀÏ ±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ½ÃÀå ±âȸ : Á¦Ç°º°

Á¦8Àå °í°´ »óȲ

  • °í°´ »óȲÀÇ °³¿ä

Á¦9Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¼¼°èÀÇ ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2023-2028
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ

  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå µ¿Çâ

Á¦11Àå º¥´õ ±¸µµ

  • °³¿ä
  • º¥´õ ±¸µµ
  • È¥¶õÀÇ »óȲ
  • ¾÷°èÀÇ ¸®½ºÅ©

Á¦12Àå º¥´õ ºÐ¼®

  • ´ë»ó º¥´õ
  • º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • Abbott Laboratories
  • Acandis GmbH
  • BALT Group
  • Boston Scientific Corp.
  • Braile Biomedica
  • Cook Group Inc.
  • Eisai Co. Ltd.
  • Embolx Inc.
  • Johnson and Johnson Services Inc.
  • Medtronic
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • Shape Memory Medical Inc.
  • Stryker Corp.
  • Terumo Corp.

Á¦13Àå ºÎ·Ï

KSA 24.04.12

The vascular embolization devices market is forecasted to grow by USD 735.35 mn during 2023-2028, accelerating at a CAGR of 6.69% during the forecast period. The report on the vascular embolization devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of vascular diseases, a rising number of new product launches related to vascular embolization devices, and a growing number of m and activities in related vascular disease products.

Technavio's vascular embolization devices market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.94%
CAGR6.69%
Incremental Value$735.35mn

By End-user

  • Hospitals
  • Speciality clinics
  • ASCs

By Product

  • Coiling devices
  • Non-coiling devices

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rise in cases of automobile accidents as one of the prime reasons driving the vascular embolization devices market growth during the next few years. Also, funding for start-up embolization device companies from venture capitalists and government organizations and innovation in embolization products and procedures will lead to sizable demand in the market.

The report on the vascular embolization devices market covers the following areas:

  • Vascular embolization devices market sizing
  • Vascular embolization devices market forecast
  • Vascular embolization devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vascular embolization devices market vendors that include Acandis GmbH, B.Braun SE, BALT Group, Boston Scientific Corp., Braile Biomedica, Eisai Co. Ltd., Embolx Inc., Guerbet, Johnson and Johnson Services Inc., Kaneka Corp., Medtronic, Merit Medical Systems Inc., Penumbra Inc., Shape Memory Medical Inc., Spartan Micro Inc., Stryker Corp., Wallby Medical LLC, Terumo Corp., Cook Group Inc., and Abbott Laboratories. Also, the vascular embolization devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global vascular embolization devices market 2018 - 2022
  • 4.2 End-user Segment Analysis 2018 - 2022
  • 4.3 Product Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022
  • 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by End-user

  • 6.1 Market segments
  • 6.2 Comparison by End-user
  • 6.3 Hospitals - Market size and forecast 2023-2028
  • 6.4 Speciality clinics - Market size and forecast 2023-2028
  • 6.5 ASCs - Market size and forecast 2023-2028
  • 6.6 Market opportunity by End-user

7 Market Segmentation by Product

  • 7.1 Market segments
  • 7.2 Comparison by Product
  • 7.3 Coiling devices - Market size and forecast 2023-2028
  • 7.4 Non-coiling devices - Market size and forecast 2023-2028
  • 7.5 Market opportunity by Product

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 Germany - Market size and forecast 2023-2028
  • 9.9 France - Market size and forecast 2023-2028
  • 9.10 UK - Market size and forecast 2023-2028
  • 9.11 Japan - Market size and forecast 2023-2028
  • 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 Abbott Laboratories
  • 12.4 Acandis GmbH
  • 12.5 BALT Group
  • 12.6 Boston Scientific Corp.
  • 12.7 Braile Biomedica
  • 12.8 Cook Group Inc.
  • 12.9 Eisai Co. Ltd.
  • 12.10 Embolx Inc.
  • 12.11 Johnson and Johnson Services Inc.
  • 12.12 Medtronic
  • 12.13 Merit Medical Systems Inc.
  • 12.14 Penumbra Inc.
  • 12.15 Shape Memory Medical Inc.
  • 12.16 Stryker Corp.
  • 12.17 Terumo Corp.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦